The Heart Failure Frequent Flyer Programme changes the trajectories of patients with chronic heart failure
CHF is a frequent cause of hospitalisation at HTAR – a total of 1,140 patients were admitted for CHF between April 2017 and April 2018, with a mean length of stay of 8.2 days. In addition to causing high mortality, hospitalisation for HF (HHF) also places a significant financial burden on patients and the healthcare system. Notably, frequent hospitalisation strongly predicts mortality among patients with CHF – approximately 93% of CHF patients treated at HTAR have recent histories of recurrent admission to the hospital for worsening HF.
The Heart Failure Frequent Flyer Programme was set up with the principal goal of reducing hospitalisation in patients with CHF to improve functional status, quality of life (QoL) and cost of care.The Programme is conducted via a holistic and multidisciplinary approach, incorporating a dedicated HF team (consisting of clinical specialists, clinical pharmacists, HF nurses, dietitian and cardiac rehabilitation team), pharmacist-led patient counselling sessions, as well as nurse-led telemonitoring and SOS walk-in services.